ELGX News and Press, Endologix Inc.

Shares of Enthusiast Gaming (TSX:EGLX) (NASDAQ:ELGX) soared up to 37% on Tuesday, as the company announced its first-quarter earnings. Enthusiast saw revenue climb 57% year over year to $47.2 million Gross profit jumped 127% to $13.5 million Subscriptions also climbed ...

After evaluating a variety of strategic options, Endologix (NASDAQ: ELGX ) has initiated a voluntary case under Chapter 11 of the U.S. Bankruptcy Code and simultaneously filed a consensual plan of reorganization supported by Deerfield Partners as its largest creditor. More...

  Commences voluntary Chapter 11 process with access to $30.8 million in DIP financing Files consensual plan of reorganization that would reduce approximately $180 million in debt and provide an approximately $30 million in additional exit financing Confirms launch of Alto thi...

MENLO PARK, Calif. , June 25, 2020 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest-growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced two key hires: Sam Park , joining as Chief Operat...

Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that Vaseem Mahboob, Chief Financial Officer (CFO), will be departing the Company effective July 1, 2020 to become...

Endologix ® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that a correction notice has been issued for the Ovation iX system, that identifies the root cause of polym...

Endologix, Inc. (ELGX) Q1 2020 Results Conference Call May 11, 2020 04:30 PM ET Company Participants John Onopchenko - CEO Vaseem Mahboob - CFO Matthew Thompson - Chief Medical Officer Conference Call Participants Mathew Blackman - Stifel Marie Thibault - BTIG Allen Gon...

The following slide deck was published by Endologix, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Endologix (NASDAQ: ELGX ): Q1 GAAP EPS of -$0.90 misses by $0.20 . More news on: Endologix, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

Endologix ® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has completed enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascul...